Janice M. Walshe

Palbociclib and Letrozole in Advanced Breast Cancer

Richard S. Finn, Miguel Martín, Hope S. Rugo et al. · New England Journal of Medicine · 2016 · 2.8K citations

Interrupting Endocrine Therapy to Attempt Pregnancy after Breast Cancer

Ann H. Partridge, Samuel M. Niman, Monica Ruggeri et al. · New England Journal of Medicine · 2023 · 202 citations · Full text

Overall survival (OS) with first-line palbociclib plus letrozole (PAL+LET) versus placebo plus letrozole (PBO+LET) in women with estrogen receptor–positive/human epidermal growth factor receptor 2–negative advanced breast cancer (ER+/HER2− ABC): Analyses from PALOMA-2.

Richard S. Finn, Hope S. Rugo, Véronique Dièras et al. · Journal of Clinical Oncology · 2022 · 169 citations

Breast Oncology, First-line Palbociclib, Lba1003 Background +16

Phase II Trial of Ixabepilone, an Epothilone B Analog, in Patients With Metastatic Breast Cancer Previously Untreated With Taxanes

Neelima Denduluri, Jennifer A. Low, James J. Lee et al. · Journal of Clinical Oncology · 2007 · 166 citations · Full text

Use of letrozole after aromatase inhibitor-based therapy in postmenopausal breast cancer (NRG Oncology/NSABP B-42): a randomised, double-blind, placebo-controlled, phase 3 trial

Eleftherios P. Mamounas, Hanna Bandos, Barry C. Lembersky et al. · The Lancet Oncology · 2018 · 158 citations · Full text

Postmenopausal Breast Cancer, Oncology, Breast Oncology +12